Oral pharmaceutical extended release dosage form

摘要

An enteric coated pharmaceutical extended release dosage form of an H<+>,K<+>-ATPase inhibitor giving an extended plasma concentration profile of an H<+>,K<+>-ATPase inhibitor. The extended plasma profile is obtained by a pharmaceutical composition which comprises a core material of a hydrophilic or hydrophobic matrix, and the H<+>,K<+>-ATPase inhibitor and optionally pharmaceutically acceptable excipients. The dosage form may be administered once daily.